Eli Lilly and Company

Eli Lilly and Company leverages its Twitter platform to disseminate groundbreaking research and patient-centric initiatives, fostering dialogue around complex conditions like IBD, NSCLC, and eczema. With a strong presence at scientific congresses like ECCO26, Lilly is an ideal partner for pharmaceutical insights, healthcare innovation, and patient advocacy campaigns seeking to reach a well-informed audience.